Not all arrestins are created equal: Therapeutic implications of the functional diversity of the β arrestins in the heart

This publication has 65 references indexed in Scilit:

• SUMO1-dependent modulation of SERCA2a in heart failure
  Nature, 2011
• Therapeutic potential of β-arrestin- and G protein-biased agonists
  Trends in Molecular Medicine, 2011
• Crystal Structure of Arrestin-3 Reveals the Basis of the Difference in Receptor Binding Between Two Non-visual Subtypes
  Journal of Molecular Biology, 2011
• Adrenal Beta-Arrestin 1 Inhibition In Vivo Attenuates Post-Myocardial Infarction Progression to Heart Failure and Adverse Remodeling Via Reduction of Circulating Aldosterone Levels
  JACC, 2011
• An adrenal β-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivo
  Proceedings of the National Academy of Sciences, 2009
• β-Blockers alprenolol and carvedilol stimulate β-arrestin-mediated EGFR transactivation
  Proceedings of the National Academy of Sciences, 2008
• A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
  Proceedings of the National Academy of Sciences, 2007
• Functional specialization of β-arrestin interactions revealed by proteomic analysis
  Proceedings of the National Academy of Sciences, 2007
• β-Arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes
  Proceedings of the National Academy of Sciences, 2006
• A polymorphism within a conserved β₁-adrenergic receptor motif alters cardiac function and β-blocker response in human heart failure
  Proceedings of the National Academy of Sciences, 2006